The 340B program, a drug discount program created by Congress through the Veterans Health Care Act of 1992,1 offers safety-net hospitals and other health care organizations eligible for 340B designation (“covered entities”) with large shares of low-income, vulnerable patients access to discounted drug pricing. This allows them to stretch resources to help more patients and provide more comprehensive services.2
Kantarjian H, Chapman R. Value of the 340B Drug Discount Program. JAMA Oncol. 2015;1(8):1029–1030. doi:10.1001/jamaoncol.2015.2168
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.